 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: March 2026
Volume 11 | Issue 3
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 11
Issue Published : 118
Article Submitted : 21574
Article Published : 8528
Total Authors : 22430
Total Reviewer : 805
Total Countries : 159
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Pharmacological Convergence in Lung Carcinoma: Molecular Pathways, Therapeutic Targets, and Emerging Nanotechnological Interventions |
| Authors Name: | Neha Gaikwad , Vasim Aparadh , Saniya Mullani , Samina Mujawar , Vishakha Gurav |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_208058
|
| Published Paper Id: | IJRTI2511173 |
| Published In: | Volume 10 Issue 11, November-2025 |
| DOI: | |
| Abstract: | The leading cause of cancer-related death worldwide is still lung cancer, which is mostly caused by cigarette smoking but is also influenced by radiation exposure, occupational carcinogens, environmental contaminants, and genetics. The majority of patients continue to be diagnosed at advanced stages, leading to few curative options and low overall survival, despite significant advancements in clinical evaluation—including the development of the TNM classification system, minimally invasive biopsy procedures, and improved imaging modalities. Small cell lung cancer (SCLC) is primarily treated with chemoradiation because of its rapid progression and early metastatic potential, while non-small cell lung cancer (NSCLC) is treated with a combination of surgery, chemotherapy, radiotherapy, targeted molecular therapies, and immunotherapy. Immune checkpoint inhibitors and the identification of actionable genetic alterations have fundamentally changed therapy paradigms, providing better results for some patient populations. Additionally, new drug delivery methods based on nanotechnology, like liposomes, nanoparticles, and nanocomposites, have the potential to improve therapeutic selectivity, reduce systemic toxicity, and overcome resistance mechanisms. The overall prognosis is still difficult despite these developments, highlighting the need for effective preventative programs, early diagnosis techniques, individualized treatment plans, and ongoing research into cutting-edge therapeutic technology targeted at enhancing long-term survival. |
| Keywords: | Lung cancer, Pathology, Epidemiology, Nanotechnology, Drug delivery |
| Cite Article: | "Pharmacological Convergence in Lung Carcinoma: Molecular Pathways, Therapeutic Targets, and Emerging Nanotechnological Interventions", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 11, page no.b652-b664, November-2025, Available :http://www.ijrti.org/papers/IJRTI2511173.pdf |
| Downloads: | 000195 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2511173
Registration ID:208058
Published In: Volume 10 Issue 11, November-2025
DOI (Digital Object Identifier):
Page No: b652-b664 Country: Kagal, Kolhapur , Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2511173 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2511173 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2026 - All Rights Reserved - IJRTI | |||